Amfepramon

Izvor: Wikipedija
Prijeđi na navigaciju Prijeđi na pretragu
Amfepramon
(IUPAC) ime
2-(dietilamino)-1-fenilpropan-1-on
Klinički podaci
Robne marke Adiposon, Amfepramon, Amfepramone, Amphepramon
AHFS/Drugs.com Monografija
Identifikatori
CAS broj 134-80-5
ATC kod A08AA03
PubChem[1][2] 7029
DrugBank DB00937
ChemSpider[3] 6762
KEGG[4] C06954 DaY
ChEMBL[5] CHEMBL4530 DaY
Hemijski podaci
Formula C13H19NO 
Mol. masa 205.2961
SMILES eMolekuli & PubHem
Farmakokinetički podaci
Poluvreme eliminacije 4 do 6 sata.
Izlučivanje Renalno
Farmakoinformacioni podaci
Trudnoća ?
Pravni status
Način primene Oralno; Oralno;

Amfepramon je depresant apetita. Smatra se da u manjoj meri uzrokuje poremećaje u centralnom nervnom sistemu od većine drugih lekova ove terapeutske kategorije. Takođe se smatra da je on među najbezbednijim lekovima za patijente sa hipertenzijom.[6][7][8][9][10]

Reference[uredi | uredi kod]

  1. Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today 15 (23-24): 1052-7. DOI:10.1016/j.drudis.2010.10.003. PMID 20970519.  edit
  2. Evan E. Bolton, Yanli Wang, Paul A. Thiessen, Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry 4: 217-241. DOI:10.1016/S1574-1400(08)00012-1. 
  3. Hettne KM, Williams AJ, van Mulligen EM, Kleinjans J, Tkachenko V, Kors JA. (2010). „Automatic vs. manual curation of a multi-source chemical dictionary: the impact on text mining”. J Cheminform 2 (1): 3. DOI:10.1186/1758-2946-2-3. PMID 20331846.  edit
  4. Joanne Wixon, Douglas Kell (2000). „Website Review: The Kyoto Encyclopedia of Genes and Genomes — KEGG”. Yeast 17 (1): 48–55. DOI:10.1002/(SICI)1097-0061(200004)17:1<48::AID-YEA2>3.0.CO;2-H. 
  5. Gaulton A, Bellis LJ, Bento AP, Chambers J, Davies M, Hersey A, Light Y, McGlinchey S, Michalovich D, Al-Lazikani B, Overington JP. (2012). „ChEMBL: a large-scale bioactivity database for drug discovery”. Nucleic Acids Res 40 (Database issue): D1100-7. DOI:10.1093/nar/gkr777. PMID 21948594.  edit
  6. AMA Drug Evaluations Annual, 1994, p2290
  7. Adan RA, Vanderschuren LJ, la Fleur SE: Anti-obesity drugs and neural circuits of feeding. Trends Pharmacol Sci. 2008 Apr;29(4):208-17. Epub 2008 Mar 18. PMID 18353447
  8. Arias HR, Santamaria A, Ali SF: Pharmacological and neurotoxicological actions mediated by bupropion and diethylpropion. Int Rev Neurobiol. 2009;88:223-55. PMID 19897080
  9. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS (2011). „DrugBank 3.0: a comprehensive resource for omics research on drugs”. Nucleic Acids Res. 39 (Database issue): D1035-41. PMID 21059682. 
  10. Wishart DS, Knox C, Guo AC, Cheng D, Shrivastava S, Tzur D, Gautam B, Hassanali M (2008). „DrugBank: a knowledgebase for drugs, drug actions and drug targets”. Nucleic Acids Res 36 (Database issue): D901-6. PMID 18048412. 

Spoljašnje veze[uredi | uredi kod]